Open AccessRecurrent malignant melanoma of the uterine cervix treated with anti‑PD‑1 antibodies and anti‑CTLA‑4 antibodies: A case report
Author(s) -
Kenbun Sone,
Asako Kukita,
Yuri Masui,
Daisuke Yamada,
Aya ShinozakiUshiku,
Akihiro Kawata,
Ayumi Taguchi,
Yukio Miyamoto,
Michihiro Tanikawa,
Takayuki Iriyama,
Mayuyo MoriUchino,
Tetsushi Tsuruga,
Yutaka Osuga
Publication year - 2022
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2022.2496
Subject(s) - medicine , nivolumab , ipilimumab , lymph node , cervix , melanoma , cervical cancer , cancer , antibody , hysterectomy , oncology , surgery , immunotherapy , immunology , cancer research